272 related articles for article (PubMed ID: 28489727)
1. Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study.
Meijer B; Wilhelm AJ; Mulder CJJ; Bouma G; van Bodegraven AA; de Boer NKH
Ther Drug Monit; 2017 Aug; 39(4):399-405. PubMed ID: 28489727
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
Armstrong L; Sharif JA; Galloway P; McGrogan P; Bishop J; Russell RK
Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
Dervieux T; Meyer G; Barham R; Matsutani M; Barry M; Boulieu R; Neri B; Seidman E
Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis.
Wusk B; Kullak-Ublick GA; Rammert C; von Eckardstein A; Fried M; Rentsch KM
Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1407-13. PubMed ID: 15618853
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR
Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy.
Derijks LJ; Gilissen LP; Engels LG; Bos LP; Bus PJ; Lohman JJ; Curvers WL; Van Deventer SJ; Hommes DW; Hooymans PM
Ther Drug Monit; 2004 Jun; 26(3):311-8. PubMed ID: 15167634
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
Thomas CW; Lowry PW; Franklin CL; Weaver AL; Myhre GM; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
Inflamm Bowel Dis; 2003 Jul; 9(4):237-45. PubMed ID: 12902847
[TBL] [Abstract][Full Text] [Related]
11. Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease.
Ohtsuka Y; Arai K; Aoyagi Y; Fujii T; Yamakawa Y; Ohtani K; Ikuse T; Baba Y; Inage E; Kudo T; Suzuki R; Nagata S; Shimizu T
J Gastroenterol Hepatol; 2010 Oct; 25(10):1626-30. PubMed ID: 20880170
[TBL] [Abstract][Full Text] [Related]
12. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides.
Duley JA; Florin TH
Ther Drug Monit; 2005 Oct; 27(5):647-54. PubMed ID: 16175140
[TBL] [Abstract][Full Text] [Related]
15. Severe hepatotoxicity with high 6-methylmercaptopurine nucleotide concentrations after thiopurine dose escalation due to low 6-thioguanine nucleotides.
Gardiner SJ; Gearry RB; Burt MJ; Ding SL; Barclay ML
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1238-42. PubMed ID: 18989148
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanine.
Jharap B; de Boer N; Vos R; Smid K; Zwiers A; Peters G; Mulder C; Wilhelm A; van Bodegraven A
Br J Pharmacol; 2011 Jun; 163(4):722-31. PubMed ID: 21323897
[TBL] [Abstract][Full Text] [Related]
17. Algorithms outperform metabolite tests in predicting response of patients with inflammatory bowel disease to thiopurines.
Waljee AK; Joyce JC; Wang S; Saxena A; Hart M; Zhu J; Higgins PD
Clin Gastroenterol Hepatol; 2010 Feb; 8(2):143-50. PubMed ID: 19835986
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
Teml A; Schaeffeler E; Herrlinger KR; Klotz U; Schwab M
Clin Pharmacokinet; 2007; 46(3):187-208. PubMed ID: 17328579
[TBL] [Abstract][Full Text] [Related]
19. Prediction of 6-thioguanine nucleotides levels in Japanese patients with inflammatory bowel diseases during long-term thiopurine administration.
Kochi S; Matsumoto T; Esaki M; Jo Y; Iida M
Scand J Gastroenterol; 2010 May; 45(5):608-14. PubMed ID: 20163203
[TBL] [Abstract][Full Text] [Related]
20. Possibilities for therapeutic drug monitoring of azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells.
Bergan S; Rugstad HE; Klemetsdal B; Giverhaug T; Bentdal O; Sødal G; Hartmann A; Aarbakke J; Stokke O
Ther Drug Monit; 1997 Jun; 19(3):318-26. PubMed ID: 9200774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
